GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Gross Profit

Toleranzia AB (OSTO:TOL) Gross Profit : kr45.33 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Gross Profit?

Toleranzia AB's gross profit for the three months ended in Mar. 2024 was kr4.69 Mil. Toleranzia AB's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was kr45.33 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Toleranzia AB's gross profit for the three months ended in Mar. 2024 was kr4.69 Mil. Toleranzia AB's Revenue for the three months ended in Mar. 2024 was kr0.00 Mil. Therefore, Toleranzia AB's Gross Margin % for the quarter that ended in Mar. 2024 was %.

Toleranzia AB had a gross margin of % for the quarter that ended in Mar. 2024 => No sustainable competitive advantage

During the past 10 years, the highest Gross Margin % of Toleranzia AB was 1953.03%. The lowest was 444.98%. And the median was 1199.01%.


Toleranzia AB Gross Profit Historical Data

The historical data trend for Toleranzia AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Toleranzia AB Gross Profit Chart

Toleranzia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.99 12.14 27.12 35.26 50.78

Toleranzia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.13 19.66 9.79 11.20 4.69

Competitive Comparison of Toleranzia AB's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Toleranzia AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Toleranzia AB's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Toleranzia AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where Toleranzia AB's Gross Profit falls into.



Toleranzia AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Toleranzia AB's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=0 - -50.778
=50.78

Toleranzia AB's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=0 - -4.687
=4.69

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr45.33 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Toleranzia AB's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=4.69 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Toleranzia AB  (OSTO:TOL) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Toleranzia AB had a gross margin of % for the quarter that ended in Mar. 2024 => No sustainable competitive advantage


Toleranzia AB Gross Profit Related Terms

Thank you for viewing the detailed overview of Toleranzia AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Toleranzia AB (OSTO:TOL) Business Description

Traded in Other Exchanges
N/A
Address
Erik Dahlbergsgatan 11A, Gothenburg, SWE, SE-411 26
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.